Literature DB >> 27651721

The relationship between first-trimester pregnancy-associated plasma protein-A levels and intrapartum fetal distress development.

Ayşe Filiz Avşar1, Elçin İşlek Seçen2, Gülin Feykan Yeğin Akçay2, Hüseyin Levent Keskin2, Emre Erdem Taş1, Ahmet Ferit Dalgacı2.   

Abstract

OBJECTIVE: To investigate the relationship between the development of intrapartum fetal distress and serum pregnancy-associated plasma protein-A (PAPP-A) levels measured during first-trimester aneuploidy screening tests.
MATERIAL AND METHODS: This retrospective study included 283 uncomplicated pregnancies that resulted in full-term live births via spontaneous labor or with the induction by oxytocin. Cases were divided into two groups based on whether their first-trimester PAPP-A multiple of the median (MoM) levels were ≤0.5 (Group 1, n=75) or >0.5 (Group 2, n=208). As primary end points, the rate of cesarean section (C/S), the rate of C/S due to fetal distress, and the umbilical artery blood pH values in cases of C/S for fetal distress were compared between the two groups. Statistical analyses were performed using the Chi-square test and independent samples t-test. P≤0.05 were considered statistically significant.
RESULTS: The mean gestational age at birth and the birth weights were significantly lower in Group 1 than in Group 2 (p=0.002 and p=0.007, respectively). Although the rate of C/S was similar between the groups (p=0.823), the rate of C/S due to fetal distress was significantly higher in Group 1 than in Group 2 (68.4% vs. 42%, respectively; p=0.050) and the mean umbilical artery blood pH value for C/S deliveries indicated by fetal distress was lower (p=0.048) in Group 1 than in Group 2. When the mode of delivery was analyzed according to the application of labor induction, both the C/S delivery rates (31.6% in Group 1 and 31.7% in Group 2; p=0.992) and C/S delivery rates due to fetal distress (66.7% in Group 1 and 46.2% in Group 2; p=0.405) were similar in both groups.
CONCLUSION: Low PAPP-A levels (≤0.5 MoM) in the first trimester are associated with the risk of intrapartum fetal distress development and the likelihood of C/S for fetal distress. Nonetheless, this risk is not affected by labor induction.

Entities:  

Keywords:  Cesarean section; fetal distress; pregnancy-associated plasma protein A

Year:  2016        PMID: 27651721      PMCID: PMC5019829          DOI: 10.5152/jtgga.2016.16022

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  14 in total

1.  Clinical fetal monitoring. VII. The evaluation and significance of intrapartum baseline FHR variability.

Authors:  R H Paul; A K Suidan; S Yeh; B S Schifrin; E H Hon
Journal:  Am J Obstet Gynecol       Date:  1975-09-15       Impact factor: 8.661

2.  Characterization of four human pregnancy-associated plasma proteins.

Authors:  T M Lin; S P Galbert; D Kiefer; W N Spellacy; S Gall
Journal:  Am J Obstet Gynecol       Date:  1974-01-15       Impact factor: 8.661

3.  Studies on pregnancy-associated plasma protein A in the third trimester of pregnancy.

Authors:  R Smith; P Bischof; G Hughes; A Klopper
Journal:  Br J Obstet Gynaecol       Date:  1979-11

4.  The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.

Authors:  J B Lawrence; C Oxvig; M T Overgaard; L Sottrup-Jensen; G J Gleich; L G Hays; J R Yates; C A Conover
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth.

Authors:  Gordon C S Smith; Emily J Stenhouse; Jennifer A Crossley; David A Aitken; Alan D Cameron; J Michael Connor
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

6.  First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses.

Authors:  K Spencer; N J Cowans; K Avgidou; F Molina; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2008-01       Impact factor: 7.299

Review 7.  Low pregnancy-associated plasma protein A level in the first trimester.

Authors:  Lise Huynh; John Kingdom; Sabrina Akhtar
Journal:  Can Fam Physician       Date:  2014-10       Impact factor: 3.275

8.  First-trimester maternal serum screening and the risk for fetal distress during labor.

Authors:  Stefano Uccella; Giacomo Filippo Colombo; Carlo Maria Bulgheroni; Maurizio Serati; Giorgio Bogani; Stefano Salvatore; Fabio Ghezzi; Pierfrancesco Bolis
Journal:  Am J Obstet Gynecol       Date:  2009-08       Impact factor: 8.661

9.  Assay of a placental protein to determine fetal risk.

Authors:  G Hughes; P Bischof; G Wilson; A Klopper
Journal:  Br Med J       Date:  1980-03-08

10.  First- and second-trimester evaluation of risk for Down syndrome.

Authors:  Robert H Ball; Aaron B Caughey; Fergal D Malone; David A Nyberg; Christine H Comstock; George R Saade; Richard L Berkowitz; Susan J Gross; Lorraine Dugoff; Sabrina D Craigo; Ilan E Timor-Tritsch; Stephen R Carr; Honor M Wolfe; Danielle Emig; Mary E D'Alton
Journal:  Obstet Gynecol       Date:  2007-07       Impact factor: 7.661

View more
  3 in total

1.  Is there any relationship between low PAPP-A levels and measures of umbilical vein and placental thickness during first trimester of pregnancy?

Authors:  Gulsum Uysal; Sadan Tutus; Fulya Cagli; Cevdet Adiguzel
Journal:  North Clin Istanb       Date:  2017-05-10

2.  Prediction performance of serum placental growth factor (PLGF) human chorionic gonadotropin β (β-hCG) and PAPP-A levels in early pregnancy for pregnancy outcomes.

Authors:  Xiao Guo; Feng Wang; Jing Li; Zhankun Guo; Jing Wang
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

3.  Low First Trimester Pregnancy-Associated Plasma Protein-A Levels Are Not Associated with an Increased Risk of Intrapartum Fetal Compromise or Adverse Neonatal Outcomes: A Retrospective Cohort Study.

Authors:  Jessica M Turner; Sailesh Kumar
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.